Circulating Lipoproteins in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy

被引:6
作者
Aaseth, Jan O. [1 ,2 ]
Rootwelt, Helge [3 ]
Retterstol, Kjetil [4 ,5 ]
Hestad, Knut [1 ,2 ]
Farup, Per G. [1 ,6 ]
机构
[1] Innlandet Hosp Trust, Dept Res, N-2381 Brumunddal, Norway
[2] Inland Norway Univ Appl Sci, Fac Hlth & Social Sci, Dept Hlth & Nursing Sci, N-2418 Elverum, Norway
[3] Oslo Univ Hosp, Dept Med Biochem, N-0424 Oslo, Norway
[4] Univ Oslo, Inst Basic Med Sci, Dept Nutr, N-0317 Oslo, Norway
[5] Oslo Univ Hosp, Lipid Clin, N-0424 Oslo, Norway
[6] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Clin & Mol Med, N-7491 Trondheim, Norway
关键词
dyslipidemia; cholesterol; HDL; LDL; lipoprotein(a); morbid obesity; gastric bypass; gastric sleeve; CHOLESTEROL; RISK;
D O I
10.3390/nu14122381
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The efficacy of various bariatric procedures on the mitigation of the obese dyslipidemia remains debated, and the impact of these measures on lipoprotein(a) (Lp(a)) levels is unknown. In this study we aimed to compare the two most commonly used procedures: gastric bypass (RYGB) and sleeve gastrectomy (SG). Adult patients with morbid obesity were assigned to receive either RYGB or SG. The levels of non-HDL cholesterol, LDL/HDL-ratio and Lp(a) at examinations conducted 6 and 12 months postoperatively were determined and compared to preoperative levels to estimate the efficacy of the two surgical methods. All results 6 and 12 months after surgery were used in the comparisons with the preoperative results. A linear mixed regression model for repeated analyses was used. The Lp(a) and the non-HDL cholesterol levels were considerably reduced in the RYGB group, in contrast to the minor changes in the SG group. In addition, the LDL/HDL ratio was significantly more reduced in the RYGB group when compared to the SG group. Conclusively, RYGB was found to be more efficient than SG for the mitigation of obese dyslipidemia, including preoperative high Lp(a)-levels. This might have important individual and societal implications, especially regarding the potential to reduce the risk of cardiovascular disease and the related societal costs.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Laparoscopic Sleeve Gastrectomy versus Gastric Bypass in Late Adolescents: What Is the Optimal Surgical Strategy for Morbid Obesity?
    van Mil, Stefanie Ramona
    Biter, Laser Ulas
    Grotenhuis, Brechtje Aleid
    Zengerink, Johannes Franciscus
    Mannaerts, Guido Hein Huib
    EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2016, 26 (06) : 487 - 493
  • [22] Comparison of pregnancy outcomes after bariatric surgery by sleeve gastrectomy versus gastric bypass
    Joly, Marie -Anne
    Peyronnet, Violaine
    Coupaye, Muriel
    Ledoux, Severine
    Pourtier, Nicolas
    Pencole, Lucile
    Mandelbrot, Laurent
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY-X, 2024, 22
  • [23] Krukenberg tumor after gastric bypass for morbid obesity. Bariatric surgery and gastric cancer
    Menendez, Pablo
    Villarejo, Pedro
    Padilla, David
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2013, 105 (05) : 296 - 298
  • [24] Morbid Obesity and Gastric Bypass Surgery: Biochemical Profile
    V Silvestre
    M Ruano
    Y Domínguez
    R Castro
    MC G García-Lescun
    A Rodríguez
    A Marco
    G García-Blanch
    Obesity Surgery, 2004, 14 : 1227 - 1232
  • [25] Effect of Bariatric Surgery on Bone Mineral Density: Comparison of Gastric Bypass and Sleeve Gastrectomy
    Nuria Vilarrasa
    Amador G. Ruiz de Gordejuela
    Carmen Gómez-Vaquero
    Jordi Pujol
    Iñaki Elio
    Patricia San José
    Silvia Toro
    Anna Casajoana
    José Manuel Gómez
    Obesity Surgery, 2013, 23 : 2086 - 2091
  • [26] Morbid obesity and gastric bypass surgery:: Biochemical profile
    Silvestre, V
    Ruano, M
    Domínguez, Y
    Castro, R
    García-Lescun, MCG
    Rodríguez, A
    Marco, A
    García-Blanch, G
    OBESITY SURGERY, 2004, 14 (09) : 1227 - 1232
  • [27] Helicobacter pylori Infection in Patients Undergoing Gastric Bypass Surgery for Morbid Obesity
    Andrew A Renshaw
    Jorge R Rabaza
    Anthony M Gonzalez
    Juan-Carlos Verdeja
    Obesity Surgery, 2001, 11 : 281 - 283
  • [28] Bariatric Surgery for Morbid Obesity
    Mark J Monteforte
    Charles M Turkelson
    Obesity Surgery, 2000, 10 : 391 - 401
  • [29] Bariatric Surgery With Roux-En-Y Gastric Bypass or Sleeve Gastrectomy for Treatment of Obesity and Comorbidities: Current Evidence and Practice
    Chacon, Daniel
    Bernardino, Timothy
    Geraghty, Feargal
    Rodriguez, Astrid Carrion
    Fiani, Brian
    Chadhaury, Asadulla
    Pierre-Louis, Muller
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [30] Hospital utilization 4 years after bariatric surgery: sleeve gastrectomy versus Roux-en-Y gastric bypass
    Spaniolas, Konstantinos
    Goldberg, Iliya
    Yang, Jie
    Zhu, Chencan
    Docimo, Salvatore
    Talamini, Mark A.
    Pryor, Aurora D.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2019, 15 (09) : 1465 - 1472